4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-039148
Chief Executive Officer sold 100,000 shares at an average $38.81 ($3,881,017)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2020-06-25 | Sale | −99,977 | $38.81 | $3,880,107 | 2,605,260 | D: show line 1 in the form |
| Anzalone Christopher Richard Chief Executive Officer | 2020-06-25 | Sale | −23 | $39.55 | $910 | 2,605,237 | D: show line 2 in the form |
| Open-market sales · 100,000 sh · avg $38.81 · $3,881,017 | |||||||
Loading xslF345X03/doc4.xml…